Immunohistochemistry analysis of Tau [pT231] showing staining in the cytoplasm and membrane of paraffin-embedded human brain tissue (right) compared to a negative control without primary antibody (left). To expose target proteins, antigen retrieval was performed using 10 mM sodium citrate (pH 6.0), microwaved for 8-15 min. Following antigen retrieval, tissues were blocked in 3% H2O2-methanol for 15 min at room temperature, washed with ddH2O and PBS, and then probed with Tau [pT231] Monoclonal antibody (355200) diluted in 3% BSA-PBS at a dilution of 1:20 overnight at 4°C in a humidified chamber. Tissues were washed extensively in PBST and detection was performed using a HRP-conjugated secondary antibody followed by colorimetric detection using a DAB kit. Tissues were counterstained with hematoxylin and dehydrated with ethanol and xylene to prep for mounting.
|Tested species reactivity||Human|
|Published species reactivity||Human, Mouse, Not Applicable|
|Host / Isotype||Mouse / IgG1|
|Immunogen||Paired helical filaments (PHF) tau preparation from human brain.|
|Storage buffer||PBS, pH 7.4|
|Contains||0.1% sodium azide|
|Tested Applications||Dilution *|
|ELISA (ELISA)||Assay Dependent|
|Immunohistochemistry (Paraffin) (IHC (P))||1:10-1:100|
|Western Blot (WB)||Assay Dependent|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
Promotes microtubule assembly and stability, and might be involved in the establishment and maintenance of neuronal polarity. The C-terminus binds axonal microtubules while the N- terminus binds neural plasma membrane components, suggesting that tau functions as a linker protein between both. Axonal polarity is predetermined by TAU/MAPT localization (in the neuronal cell) in the domain of the cell body defined by the centrosome. The short isoforms allow plasticity of the cytoskeleton whereas the longer isoforms may preferentially play a role in its stabilization.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
Aberrant Wnt signaling pathway in medial temporal lobe structures of Alzheimer's disease.
35-5200 was used in western blot to perform the first comprehensive Wnt pathway-focused evaluation using the entorhinal cortex and hippocampus from Alzheimer's diseased brains
|Riise J,Plath N,Pakkenberg B,Parachikova A||Journal of neural transmission (Vienna, Austria : 1996) (122:1303)||2015|
Abnormal serine phosphorylation of insulin receptor substrate 1 is associated with tau pathology in Alzheimer's disease and tauopathies.
35-5200 was used in western blot to determine the expression of abnormal serine phosphorylation of insulin receptor substrate 1 in healthy and diseased human brains
|Yarchoan M,Toledo JB,Lee EB,Arvanitakis Z,Kazi H,Han LY,Louneva N,Lee VM,Kim SF,Trojanowski JQ,Arnold SE||Acta neuropathologica (128:679)||2014|
|Not Applicable||Not Cited||
Deficient hippocampal insulin signaling and augmented Tau phosphorylation is related to obesity- and age-induced peripheral insulin resistance: a study in Zucker rats.
35-5200 was used in western blot to study Zucker rats for deficient hippocampal insulin signaling and augmented Tau phosphorylation and their link to obesity and age-induced peripheral insulin resistance
|¿polcová A,Mikulá¿ková B,Kr¿ková K,Gajdo¿echová L,Zórad ¿,Olszanecki R,Suski M,Bujak-Gi¿ycka B,¿elezná B,Maletínská L||BMC neuroscience (15:null)||2014|
Neurological characterization of mice deficient in GSK3¿ highlight pleiotropic physiological functions in cognition and pathological activity as Tau kinase.
35-5200 was used in western blot to investigate the contribution of GSK3α to neurological diseases.
|Maurin H,Lechat B,Dewachter I,Ris L,Louis JV,Borghgraef P,Devijver H,Jaworski T,Van Leuven F||Molecular brain (6:null)||2013|
|Human||Not Cited||Unique Alzheimer's disease paired helical filament specific epitopes involve double phosphorylation at specific sites.||Hoffmann R,Lee VM,Leight S,Varga I,Otvos L||Biochemistry (36:8114)||1997|